Explore
13D/13G Activist Filings
121,587 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | PCT | PureCycle Technologies, Inc. | Samlyn Capital, LLC | 13G/A | 7.2% | 13.6M |
| Nov 14, 2025 | KZR | Kezar Life Sciences, Inc. | Avidity Partners Management LP | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | RVT | ROYCE SMALL-CAP TRUST, INC. | BANK OF AMERICA CORP /DE/ | 13G/A | 4.9% | 1.5M |
| Nov 14, 2025 | APACU | StoneBridge Acquisition II Corp | Shaolin Capital Management LLC | 13G | 6.3% | 370K |
| Nov 14, 2025 | SONM | SONIM TECHNOLOGIES INC | LYTTON LAURENCE W | 13G/A | 7.8% | 80K |
| Nov 14, 2025 | SCPH | scPharmaceuticals Inc. | LYTTON LAURENCE W | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | PTA | Cohen & Steers Tax-Advantaged Preferred Securities & Income Fund | BANK OF AMERICA CORP /DE/ | 13G/A | 7.2% | 4.0M |
| Nov 14, 2025 | MDXH | MDxHealth SA | LYTTON LAURENCE W | 13G/A | 6.4% | 3.2M |
| Nov 14, 2025 | LIQT | LIQTECH INTERNATIONAL INC | LYTTON LAURENCE W | 13G/A | 10.0% | 999K |
| Nov 14, 2025 | CAEP | Cantor Equity Partners III, Inc. | Meteora Capital, LLC | 13G/A | 5.2% | 1.5M |
| Nov 14, 2025 | AYTU | AYTU BIOPHARMA, INC | LYTTON LAURENCE W | 13G/A | 10.0% | 1.1M |
| Nov 14, 2025 | MMU | WESTERN ASSET MANAGED MUNICIPALS FUND INC. | RIVERNORTH CAPITAL MANAGEMENT, LLC | 13G/A | 6.3% | 3.4M |
| Nov 14, 2025 | NGL | NGL Energy Partners LP | BANK OF AMERICA CORP /DE/ | 13G/A | 9.2% | 11.7M |
| Nov 14, 2025 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Cormorant Asset Management, LP | 13G/A | 12.8% | 2.4M |
| Nov 14, 2025 | CNTX | Context Therapeutics Inc. | Great Point Partners, LLC | 13G/A | 5.2% | 4.7M |
| Nov 14, 2025 | GTE | GRAN TIERRA ENERGY INC. | Daniel Lau | 13G/A | 9.0% | 3.2M |
| Nov 14, 2025 | URG | UR-ENERGY INC | SEGRA CAPITAL MANAGEMENT, LLC | 13G/A | 3.1% | 11.8M |
| Nov 14, 2025 | EGHT | 8X8 INC /DE/ | BANK OF AMERICA CORP /DE/ | 13G/A | 4.3% | 5.9M |
| Nov 14, 2025 | IBIO | iBio, Inc. | SilverArc Capital Management, LLC | 13G | 10.0% | 2.2M |
| Nov 14, 2025 | N/A | Tiziana Life Sciences Ltd | Chernett Jorey | 13G/A | 6.1% | 7.3M |
| Nov 14, 2025 | JMM | Nuveen Multi-Market Income Fund | 1607 Capital Partners, LLC | 13G/A | 3.9% | 367K |
| Nov 14, 2025 | CABA | Cabaletta Bio, Inc. | Cormorant Asset Management, LP | 13G/A | 10.0% | 9.6M |
| Nov 14, 2025 | CRWV | CoreWeave, Inc. | KOPACC LLC | 13G | 2.4% | 9.4M |
| Nov 14, 2025 | VYNE | VYNE Therapeutics Inc. | Cormorant Asset Management, LP | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | EEA | EUROPEAN EQUITY FUND, INC / MD | 1607 Capital Partners, LLC | 13G/A | 25.1% | 1.7M |
| Nov 14, 2025 | RAPP | Rapport Therapeutics, Inc. | Cormorant Asset Management, LP | 13G/A | 6.7% | 3.2M |
| Nov 14, 2025 | IAF | ABRDN AUSTRALIA EQUITY FUND, INC. | 1607 Capital Partners, LLC | 13G/A | 7.1% | 1.9M |
| Nov 14, 2025 | SMHI | SEACOR Marine Holdings Inc. | Chernett Jorey | 13G/A | 4.5% | 1.2M |
| Nov 14, 2025 | PRAX | Praxis Precision Medicines, Inc. | Cormorant Asset Management, LP | 13G/A | 4.0% | 1.0M |
| Nov 14, 2025 | IGI | Western Asset Investment Grade Opportunity Trust Inc. | 1607 Capital Partners, LLC | 13G | 5.4% | 325K |
| Nov 14, 2025 | KALA | KALA BIO, Inc. | Cormorant Asset Management, LP | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | IBIO | iBio, Inc. | Cormorant Asset Management, LP | 13G | 10.0% | 2.2M |
| Nov 14, 2025 | GLO | Clough Global Opportunities Fund | RIVERNORTH CAPITAL MANAGEMENT, LLC | 13G/A | 7.0% | 3.0M |
| Nov 14, 2025 | N/A | Generation Bio Co. | SymBiosis Capital Partners, LLC | 13G | 6.3% | 422K |
| Nov 14, 2025 | N/A | NB Asset-Based Credit Fund | Neuberger Berman Group LLC | 13G | 100.0% | 6.9M |
| Nov 14, 2025 | VSTM | Verastem, Inc. | Logos Global Management LP | 13G/A | 4.8% | 3.2M |
| Nov 14, 2025 | ICLR | ICON PLC | ORBIS INVESTMENT MANAGEMENT LTD | 13G | 5.3% | 4.1M |
| Nov 14, 2025 | ERAS | Erasca, Inc. | Logos Global Management LP | 13G/A | 4.8% | 13.6M |
| Nov 14, 2025 | OKYO | OKYO Pharma Ltd | Chernett Jorey | 13G/A | 7.8% | 3.0M |
| Nov 14, 2025 | JEQ | ABRDN JAPAN EQUITY FUND, INC. | 1607 Capital Partners, LLC | 13G/A | 12.2% | 866K |
| Nov 14, 2025 | KF | KOREA FUND INC | 1607 Capital Partners, LLC | 13G/A | 4.7% | 197K |
| Nov 14, 2025 | BRKR | Bruker Corp | ORBIS INVESTMENT MANAGEMENT LTD | 13G | 8.8% | 13.4M |
| Nov 14, 2025 | AA | Alcoa Corp | Allan Gray Australia Pty Ltd | 13G/A | 5.6% | 14.4M |
| Nov 14, 2025 | BSAAU | BEST SPAC I Acquisition Corp. | RIVERNORTH CAPITAL MANAGEMENT, LLC | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | XNET | Xunlei Limited | Shenglong Zou ("Mr. Zou") | 13G/A | 5.5% | 17.2M |
| Nov 14, 2025 | OKYO | OKYO Pharma Ltd | Dauntless Investment Group, LLC | 13G/A | 6.3% | 2.4M |
| Nov 14, 2025 | TVTX | TRAVERE THERAPEUTICS, INC | JANUS HENDERSON GROUP PLC | 13G/A | 11.9% | 10.6M |
| Nov 14, 2025 | MNPR | MONOPAR THERAPEUTICS INC | JANUS HENDERSON GROUP PLC | 13G/A | 19.5% | 1.3M |
| Nov 14, 2025 | MAZE | MAZE THERAPEUTICS, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 7.3% | 3.2M |
| Nov 14, 2025 | LXEO | LEXEO THERAPEUTICS, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 11.3% | 6.1M |